
What We're Reading: Ineffective COVID-19 Drugs; Panel Advises Fourth Dose in Israel; Physician Mental Health Amid Pandemic
FDA significantly restricts the use of 2 COVID-19 monoclonal antibody treatments ineffective against the Omicron variant; an expert panel advises the Israeli government to offer a fourth COVID-19 vaccine dose to adults; there was a substantial increase in visits for mental health and substance abuse among physicians with no prior history during the pandemic.
FDA Curbs Use of 2 Drugs Ineffective Against Omicron
The FDA yesterday significantly restricted the use of 2 COVID-19 monoclonal antibody treatments manufactured by Eli Lilly and Regeneron, citing scientific evidence showing their ineffectiveness against the Omicron variant. As reported by
Israeli Expert Panel Advises Fourth COVID-19 Vaccine Dose in Adults
An expert panel advised the Israeli government today to begin offering a fourth COVID-19 vaccine dose to adults 18 years and older amid research showing the extra dose provides 3 to 5 times the level of protection against serious disease and double the protection against infection compared with 3 doses. As reported by the
Study Finds Increase in Mental Health Visits for Physicians During Pandemic
Findings of a Canadian study published recently in
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.